Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · IEX Real-Time Price · USD
5.89
0.00 (0.00%)
At close: Jul 19, 2024, 12:00 AM
5.96
+0.07 (1.19%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Skye Bioscience Employees
Skye Bioscience had 11 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,408,800
Market Cap
165.04M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
TruBridge | 3,219 |
Repare Therapeutics | 179 |
Rigel Pharmaceuticals | 147 |
Stereotaxis | 122 |
Adverum Biotechnologies | 121 |
TriSalus Life Sciences | 112 |
Syros Pharmaceuticals | 68 |
Compugen | 68 |
SKYE News
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE - GlobeNewsWire
- 7 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE - Accesswire
- 11 days ago - Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th - GlobeNewsWire
- 11 days ago - Skye Bioscience Establishes Metabolic Clinical and Scientific Advisory Board to Support Development of Nimacimab - GlobeNewsWire
- 19 days ago - Skye Bioscience Appoints Dr. Karen Smith to Board of Directors - GlobeNewsWire
- 21 days ago - Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 6 weeks ago - Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 6 weeks ago - Skye Bioscience to discontinue development of eye disease treatment - Reuters